Previous work has identified KYNU as one of the most upregulated genes in lesional skin of patients with psoriasis and atopic dermatitis (31–34), and preferential upregulation of KYNU over IDO1 and TDO corelated with disease severity in these settings (35). This evidence concerns the gene IDO1 and atopic eczema.